|
|
|
| This article has been cited by | | 1 | Safety evaluation of dermal exposure to phthalates: Metabolism-dependent percutaneous absorption | | | Masahiro Sugino,Tomomi Hatanaka,Hiroaki Todo,Yuko Mashimo,Takamasa Suzuki,Miho Kobayashi,Osamu Hosoya,Hideto Jinno,Kazuhiko Juni,Kenji Sugibayashi | | Toxicology and Applied Pharmacology.2017;328()10 | | [DOI] | | | 2 | Mometasone furoate hydrogel for scalp use:in vitroandin vivoevaluation | | | Ana Salgado,Sara Raposo,Joana Marto,Alexandra N. Silva,Sandra Simões,Helena M. Ribeiro | | Pharmaceutical Development and Technology.2014;19(5)618 | | [DOI] | | | 3 | Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment | | | Catarina Oliveira Silva,Patrícia Rijo,Jesús Molpeceres,Isabel Vitória Figueiredo,Lia Ascensão,Ana Sofia Fernandes,Amílcar Roberto,Catarina Pinto Reis | | International Journal of Pharmaceutics.2015;493(1-2)271 | | [DOI] | | | 4 | Mometasone furoate 0.1 % ointment and hydrogel: a guide to their use in corticosteroid-responsive dermatoses | | | K. A. Lyseng-Williamson | | Drugs & Therapy Perspectives.2016;32(10)407 | | [DOI] | |
|
